Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α:A study with an 11-to 173-month follow-up
Wen Deng Shuojie Wang Xin Wei Wei Yi Linqing Zhao Yao Xie Minghui Li Hongxiao Hao Ziyu Zhang Xinxin Li Weihua Cao Yaqin Zhang Shiyu Wang Zixuan Gao Linmei Yao
Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α:A study with an 11-to 173-month follow-up
Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α:A study with an 11-to 173-month follow-up
摘要
关键词
Hepatitis B virus(HBV)/HBsAg loss/Pegylated interferon α/Outcome/Hepatocellular carcinomaKey words
Hepatitis B virus(HBV)/HBsAg loss/Pegylated interferon α/Outcome/Hepatocellular carcinoma引用本文复制引用
Wen Deng,Shuojie Wang,Xin Wei,Wei Yi,Linqing Zhao,Yao Xie,Minghui Li,Hongxiao Hao,Ziyu Zhang,Xinxin Li,Weihua Cao,Yaqin Zhang,Shiyu Wang,Zixuan Gao,Linmei Yao..Clinical outcomes after HBsAg clearance in chronic hepatitis B patients treated with Peg-IFN α:A study with an 11-to 173-month follow-up[J].中国病毒学,2025,40(4):579-586,8.基金项目
The research was funded by the Beijing Research Ward Ecxellence Program,BRWEP(BRWEP2024W102170101),the capital health research and development of special public health project(2022-1-2172),the National Key Research and Development Program(2022YFC2603500,2022YFC2603505,2023YFC2306901,2023YFC2308105,2023YFC2308105),the Beijing Municipal Health Commission high-level public health technical personnel construction project,discipline leader-03-26 (BRWEP2024W102170101)
Beijing Hospitals Authority"peak"talent training program(DFL20241803),the Beijing Hospitals Authority Clinical medicine Development of special funding support(ZLRK202301). (DFL20241803)